Compliance & Validation — Documented
HIPAA, GDPR, 21 CFR Part 11
Virtual research organization running decentralized and hybrid trials on the ObvioGo platform.
ObvioHealth, founded in 2016 and headquartered in New York, operates as a virtual research organization (VRO) running decentralized and hybrid clinical trials on its ObvioGo platform, combining patient-facing apps, ePRO, and remote data capture. The company has raised Series B funding. ObvioHealth states on its own site that the platform is designed to enable compliance with HIPAA, GDPR, and FDA 21 CFR Part 11, with compliance embedded into platform workflows and infrastructure; these are the company's own conformance statements rather than cited third-party certifications, so buyers should request audit and validation evidence.
64% — Partial coverage. Coverage score — how completely Atlas documents ObvioHealth across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
HIPAA, GDPR, 21 CFR Part 11
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Mid-Size Biotech, Large Pharma, Top 20 Pharma, CRO / CDMO, Clinical Operations, Data Management
Clinical Data Management, Patient Recruitment
Series B, Founded 2016
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?
1 registered trial where ObvioHealth is the lead sponsor. Source: ClinicalTrials.gov, verified 2026-07-29.
Top conditions studied: COVID-19